Barclays Maintains Overweight on Ovintiv, Raises Price Target to $85
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $80 to $85.
Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $80 to $85.